The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
Calò
Lorenzo A
LA
Davis
Paul A
PA
D001477:Bartter Syndrome / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D019610:Cytoprotection; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D019317:Evidence-Based Medicine; D053579:Gitelman Syndrome / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D006360:Heat-Shock Proteins / Q000378:metabolism*; D051547:Heme Oxygenase-1 / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D018384:Oxidative Stress; D047494:PPAR delta / Q000378:metabolism*; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D014157:Transcription Factors / Q000378:metabolism*
D006360:Heat-Shock Proteins; D018836:Inflammation Mediators; D047494:PPAR delta; C486497:PPARGC1A protein, human; D000071248:Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; D014157:Transcription Factors; C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1